SUMMARY OF SAFETY AND EFEFCTIVENESS DATA (SSED) | 合法醫療器材資訊網

Synvisc-One is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative ... Read More

Remove synovial fluid or effusion before each SYNVISC injection. ... Provide patients with a copy of the Patient Labeling prior to use. Read More

Synvisc-One is indicated for the treatment of pain in osteoarthritis (OA) of the knee ... Provide patients with a copy of the Patient Labeling prior to use. Read More

Synvisc-One (hylan G-F 20) is the only treatment that can give you up to six months of osteoarthritis (OA) knee pain relief with a single injection. Read More

Document ID: Genzyme Pt Labeling(Feb18-09) clean.doc ... 49 Synvisc-One is indicated for the treatment of pain in osteoarthritis (OA) of the knee in ... Read More

2009年2月26日 — * An open-label repeat treatment phase of a second 6-mL injection of Synvisc-One 26 weeks after the initial treatment phase was also assessed ... Read More

Effectiveness Data is included in the product labeling at the end of this document: ... when these subjects received additional Synvisc injections. Read More

SYNVISC® (hylan G-F 20) and Synvisc-One® (hylan G-F 20) are indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed ... Read More

Synvisc-One (Hylan G-F 20 Single Intra-articular Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, ... Read More